A total of 19 patients discontinued the study early (11 taking moxonidine and eight taking ramipril, respectively). 10 withdrew because of adverse effects; seven because of insufficient blood ...

At the conclusion of the washout phase, eligible patients were randomised using the software program Rando 4.0, as provided by Solvay Pharmaceuticals (Germany), to either moxonidine (0.2mg once ...